News & Events
Created nano-gel that destroys residual cancer cells after surgery
- October 10, 2019
- Posted by: Wiley M. Wagner
- Category: Science
Cancer is a fairly serious adversary, which must be fought with the most decisive and fundamental medical measures. However, it is worth noting the fact that often patients who have undergone remission and already had almost won the cancer, again at one stage or another face its consequences, and often metastases. Most often this is due to the fact that in the place where the cancer was previously present, there are still many residual infected cells that need to be dealt with. For this purpose, a talented team of medical specialists from the University of California presented their own development of a nano-gel that can effectively eliminate residual cancer cells.
The basis of this nano-gel is a complex of antibodies that inhibit a special protein that is often used by cancer cells in order to avoid death from antibodies of the immune system – we are talking about the protein CD47, which in this case acts a little vice versa. Being induced in large quantities at the location of residual cancer cells, it quite efficiently detects and in some way marks the cancer cells found so that antibodies produced by the immune system can successfully eliminate them.
Moreover, the current iteration of the nano-gel is a fluid of a flexible type, which is convenient to apply even to places that are somewhat hidden from the eye of the surgeon – and this means that the prototype has excellent chances to become even more functional and interesting in future use, which will save even more potential lives of patients. The developers note that nano-gel has excellent properties.
They also note that preliminary tests on experimental mice showed up to 90% success, where about half of the mice showed up to 50% increased life threshold during cancer induction using nano-gel. This allows us to hope that soon the nano-gel formula will be further improved and will be suitable even for the most problematic and complex aspects of the elimination of post-cancer cells.